|
Stock Analysis PRO New!
|
|
| Risk Assessment |
|
| Trading Strategy |
|
Evaluation of United Therapeutics Corporation stock downgraded after the last trading session
(Updated on Nov 17, 2025)
The United Therapeutics Corporation stock price gained 1.18% on the last trading day (Monday, 17th Nov 2025), rising from $466.40 to $471.92. It has now gained 6 days in a row. It is not often that stock manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 2.76% from a day low at $463.95 to a day high of $476.76. The price has risen in 8 of the last 10 days and is up by 7.58% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 79 thousand more shares were traded than the day before. In total, 481 thousand shares were bought and sold for approximately $227.08 million.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 35.53% during the next 3 months and, with a 90% probability hold a price between $603.20 and $702.61 at the end of this 3-month period.
UTHR Signals & Forecast
The United Therapeutics Corporation stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $460.60 and $442.40. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, October 28, 2025, and so far it has risen 13.62%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.
Support, Risk & Stop-loss for United Therapeutics Corporation stock
United Therapeutics Corporation finds support from accumulated volume at $455.32 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $12.81 between high and low, or 2.76%. For the last week, the stock has had daily average volatility of 2.73%.
Since the United Therapeutics Corporation has been rising for 6 days in a row, the risk over the next couple of days has increased. As we cannot be certain with regards to the size of the reaction, we urge caution.
Our recommended stop-loss: $453.96 (-3.81%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 78 and this increases the risk substantially. There is a buy signal from a pivot bottom found 14 days ago.)
Trading Expectations (UTHR) For The Upcoming Trading Day Of Tuesday 18th
For the upcoming trading day on Tuesday, 18th we expect United Therapeutics Corporation to open at $470.88, and during the day (based on 14 day Average True Range), to move between $465.28 and $478.56, which gives a possible trading interval of +/-$13.29 (+/-2.86%) up or down from last closing price. If United Therapeutics Corporation takes out the full calculated possible swing range there will be an estimated 2.86% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $455.32, some $16.60 (3.52%) from the current price of $471.92, our system finds the risk reward attractive.
Is United Therapeutics Corporation stock A Buy?
United Therapeutics Corporation holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold candidate.
Current score:
0.000
Hold/Accumulate
Downgraded
Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.
Predicted Fair Opening Price
Predicted fair opening price on November 18, 2025 - $470.88 ( 0.221%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
UTHR Performance
Trading levels for UTHR
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 483.69 | 2.49% |
| R2 | 478.79 | 1.46% |
| R1 | 475.77 | 0.82% |
| Price | 471.92 | |
| S1 | 465.98 | -1.26% |
| S2 | 462.96 | -1.90% |
| S3 | 458.07 | -2.94% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 471.92 | |
| S1 | 455.32 | -3.52% |
| S2 | 417.57 | -11.52% |
| S3 | 404.81 | -14.22% |
FAQ
Click here for our free guide on how to buy United Therapeutics Corporation Stock.
Buy UTHR